UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Envelope Glycoprotein Incorporation, Not Shedding of Surface Envelope Glycoprotein (gp120/SU), Is the Primary Determinant of SU Content of Purified Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus

Journal of Virology, 2002-06, Vol.76 (11), p.5315-5325

2002

Volltextzugriff (PDF)

Prevention of SIV Infection in Macaques by (R)-9-(2-Phosphonylmethoxypropyl)adenine

Science (American Association for the Advancement of Science), 1995-11, Vol.270 (5239), p.1197-1199

1995

Volltextzugriff (PDF)

Effectiveness of Postinoculation (R)-9-(2-Phosphonylmethoxypropyl)Adenine Treatment for Prevention of Persistent Simian Immunodeficiency Virus SIVmne Infection Depends Critically on Timing of Initiation and Duration of Treatment

Journal of Virology, 1998-05, Vol.72 (5), p.4265-4273

1998

Volltextzugriff (PDF)

Cellular Proteins Bound to Immunodeficiency Viruses: Implications for Pathogenesis and Vaccines

Science (American Association for the Advancement of Science), 1992-12, Vol.258 (5090), p.1935-1938

1992

Volltextzugriff (PDF)

Chronic active hepatitis in mice caused by Helicobacter hepaticus

The American journal of pathology, 1994-10, Vol.145 (4), p.959-968

1994

Volltextzugriff (PDF)

Novel Member of the CD209 (DC-SIGN) Gene Family in Primates

Journal of Virology, 2003-01, Vol.77 (1), p.217-227

2003

Volltextzugriff (PDF)

Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160

Science (American Association for the Advancement of Science), 1992-01, Vol.255 (5043), p.456-459

1992

Volltextzugriff (PDF)

Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins

AIDS research and human retroviruses, 2004-07, Vol.20 (7), p.772-787

2004

Volltextzugriff (PDF)

Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species

JNCI : Journal of the National Cancer Institute, 1994-08, Vol.86 (16), p.1222-1227

1994

Volltextzugriff (PDF)

Role of Immune Responses against the Envelope and the Core Antigens of Simian Immunodeficiency Virus SIVmne in Protection against Homologous Cloned and Uncloned Virus Challenge in Macaques

Journal of Virology, 1999-10, Vol.73 (10), p.8201-8215

1999

Volltextzugriff (PDF)

Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS

Journal of Virology, 1991-12, Vol.65 (12), p.7025-7031

1991

Volltextzugriff (PDF)

Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine

AIDS research and human retroviruses, 1998-10, Vol.14 Suppl 3, p.S311-S319

1998

Volltextzugriff (PDF)

Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus

Journal of Virology, 1995-05, Vol.69 (5), p.3117-3124

1995

Volltextzugriff (PDF)

Limited Breadth of the Protective Immunity Elicited by Simian Immunodeficiency Virus SIVmne gp160 Vaccines in a Combination Immunization Regimen

Journal of Virology, 1999-01, Vol.73 (1), p.618-630

1999

Volltextzugriff (PDF)

Protection of Macaques against Intrarectal Infection by a Combination Immunization Regimen with Recombinant Simian Immunodeficiency Virus SIVmne gp160 Vaccines

Journal of Virology, 1999-04, Vol.73 (4), p.3134-3146

1999

Volltextzugriff (PDF)

Protection of Macaca nemestrina from Disease following Pathogenic Simian Immunodeficiency Virus (SIV) Challenge: Utilization of SIV Nucleocapsid Mutant DNA Vaccines with and without an SIV Protein Boost

Journal of Virology, 2000-12, Vol.74 (24), p.11935-11949

2000

Volltextzugriff (PDF)

Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles

AIDS research and human retroviruses, 2004-04, Vol.20 (4), p.425-434

2004

Volltextzugriff (PDF)

T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques

AIDS (London), 1994-10, Vol.8 (10), p.1391-1395

1994

Volltextzugriff (PDF)

Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo

Virology (New York, N.Y.), 1999-01, Vol.253 (2), p.259-270

1999

Volltextzugriff (PDF)

Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne)

Journal of Virology, 1988-08, Vol.62 (8), p.2587-2595

1988

Volltextzugriff (PDF)

Progression to AIDS in Macaques Is Associated with Changes in the Replication, Tropism, and Cytopathic Properties of the Simian Immunodeficiency Virus Variant Population

Virology (New York, N.Y.), 1995-03, Vol.207 (2), p.528-542

1995

Volltextzugriff (PDF)

Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver

The American journal of pathology, 1996-02, Vol.148 (2), p.509-517

1996

Volltextzugriff (PDF)

Protection of Macaques with a Simian Immunodeficiency Virus Envelope Peptide Vaccine Based on Conserved Human Immunodeficiency Virus Type 1 Sequences

Proceedings of the National Academy of Sciences - PNAS, 1991-08, Vol.88 (16), p.7126-7130

1991

Volltextzugriff (PDF)

Isolation and Characterization of a Novel Protein (X-ORF Product) from SIV and HIV-2

Science (American Association for the Advancement of Science), 1988-07, Vol.241 (4862), p.199-201

1988

Volltextzugriff (PDF)

Protection from pathogenic SIV challenge using multigenic DNA vaccines

Immunology letters, 1999-03, Vol.66 (1), p.183-188

1999

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(93)

Sprache

Englisch
(93)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(90)
Animals
(81)
Life Sciences & Biomedicine
(70)
Aids/hiv
(50)
Virology
(49)
Biological And Medical Sciences
(33)
Simian Immunodeficiency Virus - Immunology
(27)
Simian Immunodeficiency Virus
(26)
Cell Line
(25)
Humans
(25)
Molecular Sequence Data
(24)
Microbiology
(22)
Base Sequence
(21)
Fundamental And Applied Biological Sciences. Psychology
(21)
Multidisciplinary Sciences
(20)
Nucleic Acid Hybridization
(20)
Science & Technology - Other Topics
(20)
Macaca Nemestrina
(18)
Simian Acquired Immunodeficiency Syndrome - Prevention & Control
(18)
Viruses
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Virology
(19)
Virology
(12)
Journal Of Medical Primatology
(11)
Proceedings Of The National Academy Of Sciences - Pnas
(8)
Science
(7)
Aids Research And Human Retroviruses
(6)
Nature
(5)
Cell
(3)
Laboratory Animal Science
(3)
Immunology Letters
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Envelope Glycoprotein Incorporation, Not Shedding of Surface Envelope Glycoprotein (gp120/SU), Is the Primary Determinant of SU Content of Purified Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus

Prevention of SIV Infection in Macaques by (R)-9-(2-Phosphonylmethoxypropyl)adenine

Effectiveness of Postinoculation (R)-9-(2-Phosphonylmethoxypropyl)Adenine Treatment for Prevention of Persistent Simian Immunodeficiency Virus SIVmne Infection Depends Critically on Timing of Initiation and Duration of Treatment

Cellular Proteins Bound to Immunodeficiency Viruses: Implications for Pathogenesis and Vaccines

Chronic active hepatitis in mice caused by Helicobacter hepaticus

Novel Member of the CD209 (DC-SIGN) Gene Family in Primates

Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160

Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins

Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species

Role of Immune Responses against the Envelope and the Core Antigens of Simian Immunodeficiency Virus SIVmne in Protection against Homologous Cloned and Uncloned Virus Challenge in Macaques

Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS

Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine

Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus

Limited Breadth of the Protective Immunity Elicited by Simian Immunodeficiency Virus SIVmne gp160 Vaccines in a Combination Immunization Regimen

Protection of Macaques against Intrarectal Infection by a Combination Immunization Regimen with Recombinant Simian Immunodeficiency Virus SIVmne gp160 Vaccines

Protection of Macaca nemestrina from Disease following Pathogenic Simian Immunodeficiency Virus (SIV) Challenge: Utilization of SIV Nucleocapsid Mutant DNA Vaccines with and without an SIV Protein Boost

Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles

T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques

Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo

Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne)

Progression to AIDS in Macaques Is Associated with Changes in the Replication, Tropism, and Cytopathic Properties of the Simian Immunodeficiency Virus Variant Population

Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver

Protection of Macaques with a Simian Immunodeficiency Virus Envelope Peptide Vaccine Based on Conserved Human Immunodeficiency Virus Type 1 Sequences

Isolation and Characterization of a Novel Protein (X-ORF Product) from SIV and HIV-2

Protection from pathogenic SIV challenge using multigenic DNA vaccines

Suchergebnisse filtern